![Frontiers | Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters Frontiers | Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters](https://www.frontiersin.org/files/Articles/690112/fimmu-12-690112-HTML/image_m/fimmu-12-690112-g001.jpg)
Frontiers | Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
![Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment | npj Precision Oncology Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-021-00175-2/MediaObjects/41698_2021_175_Fig1_HTML.png)
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment | npj Precision Oncology
Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy - Journal of Materials Chemistry B (RSC Publishing)
![Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383520308467-fx1.jpg)
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect
![Working towards a safer and more effective oral immunotherapy – a treatment for food allergy – EAACI Patients Working towards a safer and more effective oral immunotherapy – a treatment for food allergy – EAACI Patients](https://patients.eaaci.org/wp-content/uploads/2018/11/Final-infographic-OIT-002.png)
Working towards a safer and more effective oral immunotherapy – a treatment for food allergy – EAACI Patients
![Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients - Clinical Lung Cancer Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c9d76bee-7447-4c59-a0ae-7f9394025587/gr1_lrg.jpg)
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients - Clinical Lung Cancer
![How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer - Annals of Oncology How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f09b5294-484c-4d6b-8251-49b656e13654/gr1_lrg.jpg)
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer - Annals of Oncology
![Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-020-1144-6/MediaObjects/12943_2020_1144_Fig3_HTML.png)
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
![Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Nature Biotechnology Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41587-021-01070-8/MediaObjects/41587_2021_1070_Fig1_HTML.png)
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Nature Biotechnology
![Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-020-00209-0/MediaObjects/40364_2020_209_Fig1_HTML.png)
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text
![PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | ResearchGate PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | ResearchGate](https://i1.rgstatic.net/publication/343902774_Predictive_biomarkers_for_cancer_immunotherapy_with_immune_checkpoint_inhibitors/links/5f52c8d0a6fdcc9879cda66a/largepreview.png)
PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | ResearchGate
![Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - Rezasoltani - 2021 - Cancer Medicine - Wiley Online Library Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - Rezasoltani - 2021 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/db3d99db-ed0b-4668-9c3e-feae2b5d64ca/cam43694-fig-0002-m.jpg)